Materials & Resources » Chemicals | Sharon Bio-Medicine Ltd.

Sharon Bio-Medicine Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2011
2012
2013
2014
2016
Net Income before Extraordinaries
384,897.00
542,099.00
670,382.00
854,591.00
2,178,931.00
Depreciation, Depletion & Amortization
82,512.00
87,709.00
120,350.00
152,616.00
150,146.00
Other Funds
3,449.00
2,832.00
734.00
816.00
103,441.00
Funds from Operations
427,409.00
586,580.00
658,369.00
877,107.00
2,852,514.00
Changes in Working Capital
774,559.00
1,111,701.00
1,353,564.00
1,554,016.00
2,543,985.00
Net Operating Cash Flow
347,150.00
525,121.00
695,195.00
676,909.00
308,529.00
Capital Expenditures
96,163.00
621,131.00
651,694.00
318,068.00
14,675.00
Purchase/Sale of Investments
2,505.00
1,000.00
-
27,500.00
3,278.00
Net Investing Cash Flow
93,658.00
622,131.00
651,694.00
290,568.00
11,397.00
Cash Dividends Paid - Total
19,002.00
19,002.00
15,835.00
44,464.00
-
Issuance/Reduction of Debt, Net
10,554.00
1,187,875.00
1,363,522.00
814,955.00
152,345.00
Net Financing Cash Flow
455,503.00
1,171,705.00
1,346,953.00
1,027,725.00
262,241.00
Net Change in Cash
14,695.00
24,453.00
64.00
60,248.00
57,685.00
Free Cash Flow
443,313.00
1,146,252.00
1,346,889.00
994,977.00
323,204.00
Change in Capital Stock
467,400.00
-
-
258,050.00
6,455.00

About Sharon Bio-Medicine

View Profile
Address
601, Proxima, Plot No.19
Mumbai Maharashtra 400705
India
Employees -
Website http://www.sharonbio.com
Updated 07/08/2019
Sharon Bio-Medicine Ltd. engages in the manufacturing of pharmaceutical formulations and chemical intermediates. The company provides pharmaceutical products and services include: Animal toxicology and manufacturing of finished dosages. It offers preclinical toxicology, chemical process development & scale up, formulation development, analytical method development, DMF & dossier preparation, commercial manufacturing of intermediates, activities, finished dosages and stability monitoring for the entire shelf life of the product.